2-bromo-5-[(1R,5S)-3,6-diazabicyclo[3.2.0]heptan-6-yl]pyridine-3-carbonitrile;bis((E)-but-2-enedioic acid)

C19H19BrN4O8 — CID 23634912

IUPAC2-bromo-5-[(1R,5S)-3,6-diazabicyclo[3.2.0]heptan-6-yl]pyridine-3-carbonitrile;bis((E)-but-2-enedioic acid)
SMILESN#Cc1cc(N2C[C@H]3CNC[C@H]32)cnc1Br.O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O
InChIInChI=1S/C11H11BrN4.2C4H4O4/c12-11-7(2-13)1-9(4-15-11)16-6-8-3-14-5-10(8)16;2*5-3(6)1-2-4(7)8/h1,4,8,10,14H,3,5-6H2;2*1-2H,(H,5,6)(H,7,8)/b;2*2-1+/t8-,10-;;/m1../s1
InChIKeyAYPFTGZFDONPCP-RPWWDZGESA-N
MW511.29 g/mol
LogP0.55
Rot. Bonds5

About 2-bromo-5-[(1R,5S)-3,6-diazabicyclo[3.2.0]heptan-6-yl]pyridine-3-carbonitrile;bis((E)-but-2-enedioic acid)

2-bromo-5-[(1R,5S)-3,6-diazabicyclo[3.2.0]heptan-6-yl]pyridine-3-carbonitrile;bis((E)-but-2-enedioic acid) (PubChem CID 23634912) has the molecular formula C19H19BrN4O8 and a molecular weight of 511.29 g/mol. Its IUPAC name is 2-bromo-5-[(1R,5S)-3,6-diazabicyclo[3.2.0]heptan-6-yl]pyridine-3-carbonitrile;bis((E)-but-2-enedioic acid).

Molecular Properties

Compound Name2-bromo-5-[(1R,5S)-3,6-diazabicyclo[3.2.0]heptan-6-yl]pyridine-3-carbonitrile;bis((E)-but-2-enedioic acid)
PubChem CID23634912
Molecular FormulaC19H19BrN4O8
Molecular Weight511.29 g/mol
Exact Mass510.04
IUPAC Name2-bromo-5-[(1R,5S)-3,6-diazabicyclo[3.2.0]heptan-6-yl]pyridine-3-carbonitrile;bis((E)-but-2-enedioic acid)
SMILESN#Cc1cc(N2C[C@H]3CNC[C@H]32)cnc1Br.O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O
InChIInChI=1S/C11H11BrN4.2C4H4O4/c12-11-7(2-13)1-9(4-15-11)16-6-8-3-14-5-10(8)16;2*5-3(6)1-2-4(7)8/h1,4,8,10,14H,3,5-6H2;2*1-2H,(H,5,6)(H,7,8)/b;2*2-1+/t8-,10-;;/m1../s1
InChIKeyAYPFTGZFDONPCP-RPWWDZGESA-N
XLogP0.55
TPSA201.15 Ų
H-Bond Donors5
H-Bond Acceptors8
Rotatable Bonds5
Heavy Atoms32
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500511.29
LogP ≤ 50.55
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze 2-bromo-5-[(1R,5S)-3,6-diazabicyclo[3.2.0]heptan-6-yl]pyridine-3-carbonitrile;bis((E)-but-2-enedioic acid) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-bromo-5-[(1R,5S)-3,6-diazabicyclo[3.2.0]heptan-6-yl]pyridine-3-carbonitrile;bis((E)-but-2-enedioic acid)?
The IUPAC name of 2-bromo-5-[(1R,5S)-3,6-diazabicyclo[3.2.0]heptan-6-yl]pyridine-3-carbonitrile;bis((E)-but-2-enedioic acid) (CID 23634912) is 2-bromo-5-[(1R,5S)-3,6-diazabicyclo[3.2.0]heptan-6-yl]pyridine-3-carbonitrile;bis((E)-but-2-enedioic acid).
What is the SMILES notation for 2-bromo-5-[(1R,5S)-3,6-diazabicyclo[3.2.0]heptan-6-yl]pyridine-3-carbonitrile;bis((E)-but-2-enedioic acid)?
The canonical SMILES for 2-bromo-5-[(1R,5S)-3,6-diazabicyclo[3.2.0]heptan-6-yl]pyridine-3-carbonitrile;bis((E)-but-2-enedioic acid) is N#Cc1cc(N2C[C@H]3CNC[C@H]32)cnc1Br.O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O.
What is the InChIKey of 2-bromo-5-[(1R,5S)-3,6-diazabicyclo[3.2.0]heptan-6-yl]pyridine-3-carbonitrile;bis((E)-but-2-enedioic acid)?
The InChIKey is AYPFTGZFDONPCP-RPWWDZGESA-N. The full InChI is InChI=1S/C11H11BrN4.2C4H4O4/c12-11-7(2-13)1-9(4-15-11)16-6-8-3-14-5-10(8)16;2*5-3(6)1-2-4(7)8/h1,4,8,10,14H,3,5-6H2;2*1-2H,(H,5,6)(H,7,8)/b;2*2-1+/t8-,10-;;/m1../s1.
What are the key properties of 2-bromo-5-[(1R,5S)-3,6-diazabicyclo[3.2.0]heptan-6-yl]pyridine-3-carbonitrile;bis((E)-but-2-enedioic acid)?
2-bromo-5-[(1R,5S)-3,6-diazabicyclo[3.2.0]heptan-6-yl]pyridine-3-carbonitrile;bis((E)-but-2-enedioic acid) has a molecular weight of 511.29 g/mol, XLogP of 0.55, 5 rotatable bonds, 5 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 2-bromo-5-[(1R,5S)-3,6-diazabicyclo[3.2.0]heptan-6-yl]pyridine-3-carbonitrile;bis((E)-but-2-enedioic acid) is sourced from PubChem (CID 23634912), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).